0.0973 USD
0 (-0.21%)
Last: Mar 4, 2025, 08:08 PM
Taking everything into account, ZOM scores 3 out of 10 in our fundamental rating. ZOM was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While ZOM has a great health rating, there are worries on its profitability. ZOM has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year ZOM has reported negative net income.
- ZOM had a negative operating cash flow in the past year.
- In the past 5 years ZOM always reported negative net income.
- ZOM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -29.05%, ZOM perfoms like the industry average, outperforming 43.16% of the companies in the same industry.
- The Return On Equity of ZOM (-30.66%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.05% | ||
| ROE | -30.66% | ||
| ROIC | N/A |
ROA(3y)-8.76%
ROA(5y)-104.96%
ROE(3y)-9.18%
ROE(5y)-199.7%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ZOM has a Gross Margin of 69.64%. This is in the better half of the industry: ZOM outperforms 79.47% of its industry peers.
- ZOM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- ZOM does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for ZOM remains at a similar level compared to 1 year ago.
- ZOM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 3.68 indicates that ZOM is not in any danger for bankruptcy at the moment.
- ZOM's Altman-Z score of 3.68 is fine compared to the rest of the industry. ZOM outperforms 72.63% of its industry peers.
- ZOM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.68 |
ROIC/WACCN/A
WACC8.9%
2.3 Liquidity
- ZOM has a Current Ratio of 10.82. This indicates that ZOM is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 10.82, ZOM belongs to the top of the industry, outperforming 92.63% of the companies in the same industry.
- ZOM has a Quick Ratio of 10.15. This indicates that ZOM is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 10.15, ZOM belongs to the top of the industry, outperforming 92.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.82 | ||
| Quick Ratio | 10.15 |
3. Growth
3.1 Past
- ZOM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.89%.
- Looking at the last year, ZOM shows a quite strong growth in Revenue. The Revenue has grown by 11.33% in the last year.
EPS 1Y (TTM)-57.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-900%
Revenue 1Y (TTM)11.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.29%
3.2 Future
- The Earnings Per Share is expected to decrease by -7.13% on average over the next years.
- The Revenue is expected to grow by 23.91% on average over the next years. This is a very strong growth
EPS Next Y-110.78%
EPS Next 2Y-14.78%
EPS Next 3Y-5.84%
EPS Next 5Y-7.13%
Revenue Next Year10.67%
Revenue Next 2Y19.02%
Revenue Next 3Y22.19%
Revenue Next 5Y23.91%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- ZOM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year ZOM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ZOM's earnings are expected to decrease with -5.84% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.78%
EPS Next 3Y-5.84%
5. Dividend
5.1 Amount
- No dividends for ZOM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ZOMEDICA CORP / ZOM FAQ
Can you provide the ChartMill fundamental rating for ZOMEDICA CORP?
ChartMill assigns a fundamental rating of 3 / 10 to ZOM.
Can you provide the valuation status for ZOMEDICA CORP?
ChartMill assigns a valuation rating of 0 / 10 to ZOMEDICA CORP (ZOM). This can be considered as Overvalued.
What is the profitability of ZOM stock?
ZOMEDICA CORP (ZOM) has a profitability rating of 1 / 10.